Adicet Bio Inc. (ACET)
NASDAQ: ACET
· Real-Time Price · USD
0.65
-0.02 (-2.69%)
At close: May 14, 2025, 3:59 PM
0.64
-1.85%
After-hours: May 14, 2025, 06:31 PM EDT
Adicet Bio Revenue Breakdown
| Period Ending | Jun 30, 2017 | Jun 30, 2016 | Jun 30, 2015 | Jun 30, 2014 | Jun 30, 2013 | Jun 30, 2012 |
|---|---|---|---|---|---|---|
| Human Health Revenue | 315.39M | 228.03M | 225.26M | 160.22M | 129.67M | 105.25M |
| Human Health Revenue Growth | +38.31% | +1.23% | +40.60% | +23.56% | +23.20% | n/a |
| Performance Chemicals Revenue | 165.48M | 169.48M | 172.39M | 173.54M | 185.17M | 176.14M |
| Performance Chemicals Revenue Growth | -2.36% | -1.69% | -0.66% | -6.28% | +5.13% | n/a |
| Pharmaceutical Ingredients Revenue | 157.44M | 161.01M | 149.3M | 176.43M | 184.85M | 163M |
| Pharmaceutical Ingredients Revenue Growth | -2.21% | +7.85% | -15.38% | -4.56% | +13.41% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.47M | 6.9M | 6.95M | 5.32M | 5.12M | 6.63M | 6.53M | 6.57M | 6.55M | 6.42M | 6.53M | 6.8M | 6.35M | 5.21M | 5.03M | 5.63M | 5.08M | 7.74M | 7.42M | 2.52M | 2.62M | 1.85M | 2.09M | 2.13M | -47.16M | 2.27M | 2.27M | 2.09M | -53.75M | 609K | 1.21M | 26.52M | 28.07M | 21.02M | 14.79M | 19.5M | 19.25M | 17.63M | 8.89M | 19.07M |
| Selling, General, and Administrative Revenue Growth | +8.26% | -0.69% | +30.53% | +4.01% | -22.84% | +1.61% | -0.58% | +0.24% | +2.10% | -1.75% | -4.00% | +7.07% | +21.85% | +3.74% | -10.75% | +10.91% | -34.43% | +4.34% | +193.94% | -3.77% | +42.01% | -11.75% | -1.69% | -104.51% | -2180.11% | -0.04% | +8.31% | -103.90% | -8926.44% | -49.50% | -95.45% | -5.53% | +33.52% | +42.18% | -24.16% | +1.31% | +9.15% | +98.37% | -53.38% | n/a |
| Research and Development Revenue | 23.27M | 26.25M | 25.9M | 23.9M | 24.76M | 26.17M | 28.36M | 26.76M | 25.02M | 16.57M | 16.18M | 13.48M | 14.66M | 11.93M | 10.62M | 11.74M | 9.68M | 8.94M | 8.68M | 7.03M | 6.52M | 6.33M | 5.83M | 5.01M | 24.18M | 6.76M | 11.85M | 8.11M | 9.95M | 3.33M | 2.94M | 2.61M | 1.34M | 1.05M | 1.66M | 2.32M | 2.53M | 1.43M | 2M | 2.1M |
| Research and Development Revenue Growth | -11.35% | +1.36% | +8.39% | -3.48% | -5.38% | -7.74% | +6.00% | +6.96% | +50.97% | +2.42% | +19.99% | -8.02% | +22.91% | +12.34% | -9.60% | +21.27% | +8.29% | +3.07% | +23.36% | +7.82% | +3.03% | +8.65% | +16.31% | -79.28% | +257.40% | -42.89% | +46.13% | -18.55% | +198.59% | +13.41% | +12.73% | +94.41% | +27.71% | -36.63% | -28.55% | -8.38% | +76.99% | -28.46% | -4.85% | n/a |